Stock listing
NASDAQ:XNPT XenoPort Inc Stock
Follow XenoPort Inc into a list and get an email when it puts out news.
Last close · NASDAQ:XNPT
$7.07 USD
Close on Jul 5, 2016 · No longer trades
- Lowest – highest close
- $3.28 – $65.86 USDSince Jun 2, 2005 · lowest May 9, 2014 · highest Jan 18, 2008
Delisted NASDAQ:XNPT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:XNPT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
XenoPort Inc on 6ix
- Decks
- 7 decks · latest Sep 15, 2015
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (September 2015) | Technical | 21 slides | Sep 15, 2015 |
| Investor Presentation (October 2014) | Investor deck | 45 slides | Oct 16, 2014 |
| Proxy Contest (June 2014) | Proxy contest | 50 slides | Jun 6, 2014 |
| Proxy Contest (May 2014) | Proxy contest | 51 slides | May 29, 2014 |
| Proxy Contest (May 2014) | Proxy contest | 49 slides | May 21, 2014 |
| Proxy Contest (May 2014) | Proxy contest | 52 slides | May 21, 2014 |
| Proxy Contest (May 2014) | Proxy contest | 25 slides | May 13, 2014 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jeryl Jeri Hilleman Other companies: Omada Health, Inc. (Chair, Omada Health Board of Directors · Since at least Jun 5, 2025); Hillevax Inc (Director · Since at least Apr 28, 2022); SI-BONE, Inc. (Director · Since at least Dec 3, 2019); NovoCure Limited (Director · Since at least Jul 25, 2018); Cutera Inc (Director · Jul 12, 2024 – Oct 24, 2024 · Past); Talis Biomedical Corp (Director · Mar 16, 2021 – Mar 16, 2021 · Past); Minerva Neurosciences, Inc (Director · Jul 16, 2018 – Sep 27, 2023 · Past); Intersect ENT Inc (Chief Financial Officer · Jul 23, 2014 – May 7, 2019 · Past); Ocera Therapeutics Inc (CFO and Secretary · Sep 3, 2013 – Dec 19, 2013 · Past); Amyris Inc (Chief Financial Officer · Sep 27, 2010 – May 20, 2011 · Past); Symyx Technologies Inc (Exec. Vice President and CFO · Feb 15, 2006 – Mar 1, 2007 · Past) | Director · May 2, 2006 – Jul 5, 2016 · Past |
| John G. Freund Other companies: SI-BONE, Inc. (Director · Since at least Oct 16, 2018); Collegium Pharmaceutical, Inc. (Director · Since at least May 6, 2015); Sutro Biopharma, Inc. (Director · Sep 26, 2018 – Jun 6, 2024 · Past); Protara Therapeutics, Inc. (Director · Oct 21, 2014 – Nov 8, 2019 · Past); Concert Pharmaceuticals Inc (Director · Feb 12, 2014 – Feb 20, 2014 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Dec 10, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – May 29, 2007 · Past); Hansen Medical Inc (Director · Nov 15, 2006 – Jun 17, 2009 · Past) | Director · May 2, 2006 – Jul 5, 2016 · Past |
| Wendall Wierenga Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2018); Cytokinetics, Incorporated (Director · Since at least Feb 9, 2011); Concert Pharmaceuticals Inc (Director · Mar 13, 2014 – Jun 14, 2018 · Past); Apricus Biosciences Inc (Director · Mar 10, 2014 – Jan 4, 2018 · Past); Ocera Therapeutics Inc (Director · Dec 19, 2013 – Dec 11, 2017 · Past); Santarus Inc (EVP, R&D · Jun 20, 2011 – Jan 2, 2014 · Past); Onyx Pharmaceuticals Inc (Director · Dec 15, 2008 – Oct 1, 2013 · Past) | Director · May 7, 2009 – Jul 5, 2016 · Past |
| Dennis M Fenton Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); AnaptysBio, Inc. (Director · Since at least Mar 5, 2018); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past); Pfenex Inc (Director · May 6, 2016 – May 5, 2017 · Past) | Director · May 17, 2016 – Jul 5, 2016 · Past |
| William Rieflin Other companies: Lyell Immunopharma, Inc. (Director · Since at least Jun 16, 2021); RAPT Therapeutics Inc (Director · Oct 30, 2019 – May 22, 2024 · Past); NGM Biopharmaceuticals Inc (Director · Apr 3, 2019 – Apr 5, 2024 · Past) | Director · May 17, 2016 – Jul 5, 2016 · Past |
| Gary D Tollefson Other companies: Orexigen Therapeutics Inc (President and CEO, Director · Apr 25, 2007 – Aug 15, 2008 · Past); Cypress Bioscience Inc (Director · Jan 2, 2006 – Jan 2, 2007 · Past) | Director · Feb 15, 2006 – May 8, 2008 · Past |
| Kenneth Cundy Other companies: Anebulo Pharmaceuticals, Inc. (Chief Scientific Officer · Since at least May 20, 2022); CohBar Inc (Chief Scientific Officer · Jul 18, 2018 – Aug 11, 2021 · Past) | SVP, Preclinical Development · Jan 31, 2006 – Mar 12, 2012 · Past |
| Ronald W Barrett Other companies: Janux Therapeutics, Inc. (Director · Since at least Sep 7, 2021); Concert Pharmaceuticals Inc (Director · Feb 12, 2014 – Jun 10, 2021 · Past) | Chief Executive Officer, Director · Jan 31, 2006 – Sep 1, 2015 · Past |
| William G Harris Other companies: Soleno Therapeutics, Inc. (Director · Since at least Jul 6, 2017) | See Remarks · Feb 24, 2006 – Jul 5, 2016 · Past |
| David R Savello | SVP, Development · Feb 16, 2007 – Feb 24, 2014 · Past |
All 17 people
| Person | Seat |
|---|---|
| Gianna M Bosko | SVP, CLO and Secretary · Aug 25, 2010 – Jan 13, 2015 · Past |
| Gregory T Bates | See Remarks · Jun 1, 2012 – Jul 5, 2016 · Past |
| Kim Richard | See Remarks · Jan 15, 2014 – Jul 5, 2016 · Past |
| Mark A Gallop | SVP, Research · Jan 3, 2006 – Feb 24, 2010 · Past |
| Pierre V Tran | SVP and Chief Medical Officer · Jan 31, 2006 – Jan 30, 2007 · Past |
| Robert Overell | Director · Jan 5, 2006 – Jan 5, 2006 · Past |
| Vincent Angotti | CHIEF EXECUTIVE OFFICER, Director · May 1, 2008 – Jul 5, 2016 · Past |
Log in to ask 6ix AI your own questions about XenoPort Inc.